Valuation: Azenta, Inc.

Market Cap 1.23B 1.08B 998M 916M 1.73B 119B 1.76B 11.9B 4.67B 58.08B 4.64B 4.53B 201B P/E 2026 *
-7.31x
P/E 2027 * 112x
Enterprise Value 1.23B 1.08B 998M 916M 1.73B 119B 1.76B 11.9B 4.67B 58.08B 4.64B 4.53B 201B EV / Sales 2026 *
2.06x
EV / Sales 2027 * 1.96x
Free-Float
76.62%
Yield 2026 *
-
Yield 2027 * -
1 day+0.26%
1 week+5.35%
Current month+4.94%
1 month+15.78%
3 months+10.12%
6 months-33.05%
Current year-19.48%
1 week 24.85
Extreme 24.85
26.98
1 month 21.99
Extreme 21.99
27.05
Current year 15.93
Extreme 15.93
41.73
1 year 15.93
Extreme 15.93
41.73
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 12.05
Extreme 12.05
124.79
Manager TitleAgeSince
Chief Executive Officer 45 09/09/2024
Director of Finance/CFO 49 01/12/2024
Chief Tech/Sci/R&D Officer - 01/11/2009
Director TitleAgeSince
Director/Board Member 64 28/06/2013
Director/Board Member 50 03/04/2020
Chairman 72 30/01/2024
Date Insider Type Main position Quantity % Market Cap.
18/5/26 Buy

Director

10,000 0.0217%
15/5/26 Tax

General Counsel

-3,621 0.0079%
28/4/26 Free

President Multiomics

17,790 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+5.35%-16.52%-40.61% 1.23B
-0.37%-2.35%+0.39%+5.73% 49.7B
-2.85%-6.25%+366.61%+572.09% 38.09B
+1.98%+4.82%+13.71%+61.68% 35.29B
+1.78%+0.73%+32.68%-4.80% 35.13B
+0.06%+1.56%+4.41%+27.42% 27.22B
-3.27%-5.67% - - 16.14B
+1.64%+0.45%+70.86%+121.18% 15.36B
+1.06%+1.86%+15.83%+19.58% 13.89B
-1.21%+0.73%+18.02%-30.96% 13.02B
Average -0.08%+0.03%+56.22%+81.26% 24.51B
Weighted average by Cap. -0.07%-0.61%+75.39%+115.80%

Financials

2026 *2027 *
Net sales 600M 525M 485M 445M 843M 57.86B 858M 5.79B 2.27B 28.26B 2.25B 2.21B 97.55B 630M 551M 509M 467M 885M 60.72B 900M 6.07B 2.39B 29.65B 2.37B 2.31B 102B
Net income -159M -139M -129M -118M -223M -15.34B -227M -1.53B -603M -7.49B -598M -585M -25.86B 17.3M 15.12M 13.98M 12.83M 24.29M 1.67B 24.71M 167M 65.52M 814M 64.97M 63.54M 2.81B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
16/07/26 USD 26.78 +0.26% 660,553
15/07/26 USD 26.71 +4.99% 528,258
14/07/26 USD 25.44 -2.34% 880,376
13/07/26 USD 26.05 +2.72% 575,286
10/07/26 USD 25.36 -0.24% 544,665
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
26.78USD
Average target price
26.20USD
Spread / Average Target
-2.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AZTA Stock